ABU DHABI, 28th May, 2025 (WAM) -- M42 and Cleveland Clinic Abu Dhabi, have signed a Memorandum of Cooperation (MoC) with Gunma University in Japan to accelerate research and innovation in heavy ...

Cleveland Clinic Abu Dhabi, a cornerstone of the M42 network, has earned a prestigious reputation for its world-class complex care, making it a preferred choice for patients across the globe.

The chief of M42, a joint venture between Abu Dhabi sovereign wealth fund Mubadala Investment Company and artificial intelligence (AI) firm G42, will now be overseeing Cleveland Clinic Abu Dhabi.

Abu Dhabi is set to build an advanced cancer treatment center in the Middle East, marking its latest foray into the health care sector as part of a multibillion-dollar diversification push. M42’s ...

Experts from Cleveland Clinic Abu Dhabi, part of the M42 network, will lead the charge by sharing key learnings and interventions toward excellence in healthcare at the Arab Health Exhibition and ...

Cleveland Clinic Abu Dhabi, an M42 company, is setting the benchmark for research by leading groundbreaking observational and interventional studies focused on diagnosis, prevention and therapeutics.

With this milestone accreditation, Cleveland Clinic Abu Dhabi has set its sight on attracting a global audience of medical education facilitators, organisers, and decision-makers, as we continue ...

Abu Dhabi's M42 is building one of the largest DNA databases, combining this with pharmacology and AI tools to create more personalized treatment plans.

Cleveland Clinic Abu Dhabi’s research department, ... Dr Sawsan Abdel-Razig, Chief Academic Officer at Cleveland Clinic Abu Dhabi, an M42 company, said: ...

ABU DHABI - M42 and Cleveland Clinic Abu Dhabi, have signed a Memorandum of Cooperation (MoC) with Gunma University in Japan to accelerate research and innovation in heavy ion therapy, one of the most ...